28th Feb 2019 7:00 am |
RNS |
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY |
25th Feb 2019 7:00 am |
RNS |
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX |
11th Feb 2019 7:00 am |
RNS |
Research into role of immune cells in cancer |
31st Jan 2019 7:00 am |
RNS |
Interim Results |
29th Jan 2019 7:00 am |
RNS |
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS |
11th Jan 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
11th Jan 2019 2:00 pm |
RNS |
Price Monitoring Extension |
11th Jan 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
11th Jan 2019 11:00 am |
RNS |
Price Monitoring Extension |
11th Jan 2019 9:05 am |
RNS |
Second Price Monitoring Extn |
11th Jan 2019 9:00 am |
RNS |
Price Monitoring Extension |
10th Jan 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
10th Jan 2019 4:36 pm |
RNS |
Price Monitoring Extension |
10th Jan 2019 4:01 pm |
RNS |
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX |
9th Jan 2019 7:00 am |
RNS |
Notice of Results |
21st Dec 2018 7:00 am |
RNS |
Issue of LTIP Options and Share Options |
28th Nov 2018 7:00 am |
RNS |
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR |
13th Nov 2018 5:10 pm |
RNS |
Holding(s) in Company |
5th Nov 2018 7:00 am |
RNS |
Acquisition of outstanding shares |
2nd Nov 2018 2:00 pm |
RNS |
Price Monitoring Extension |
1st Nov 2018 7:00 am |
RNS |
Appointment of Dr Jan Groen as NED |
30th Oct 2018 4:21 pm |
RNS |
Result of AGM |
29th Oct 2018 7:00 am |
RNS |
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS |
25th Oct 2018 7:00 am |
RNS |
Good Progress with FDA Studies |
9th Oct 2018 7:00 am |
RNS |
Notice of AGM |
28th Aug 2018 7:00 am |
RNS |
Parsortix shows evidence of CTCs in glioblastoma |
25th Jul 2018 7:00 am |
RNS |
Preliminary Results for year ended 30 April 2018 |
24th Jul 2018 5:42 pm |
RNS |
EIS/VCT Advance Assurance and Total Voting Rights |
18th Jul 2018 10:34 am |
RNS |
Result of General Meeting |
2nd Jul 2018 7:00 am |
RNS |
Notice of Preliminary Results |
25th Jun 2018 6:20 pm |
RNS |
Results of Fundraising |
25th Jun 2018 2:58 pm |
RNS |
Close of Accelerated Bookbuild |
25th Jun 2018 7:50 am |
RNS |
Proposed Placing of New Ordinary Shares |
4th Jun 2018 7:00 am |
RNS |
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY |
14th May 2018 7:00 am |
RNS |
Leading cancer surgeon appointed |
3rd May 2018 7:00 am |
RNS |
Angle & QIAGEN Poster |
19th Apr 2018 7:00 am |
RNS |
Parsortix in multiple presentations at AACR |
19th Apr 2018 7:00 am |
RNS |
Breakthrough Research with Parsortix |
5th Apr 2018 7:00 am |
RNS |
First patient enrolled in FDA study |
26th Mar 2018 4:35 pm |
RNS |
Price Monitoring Extension |